Company

MINAFIN (holding) : a global Fine Chem group

Minafin, with a long history of providing superior service and innovation, is at the core a manufacturer of fine chemicals, pharmaceutical intermediates and active pharmaceutical ingredients (APIs).

Today, the largest pharmaceutical and biopharmaceutical relies on Minakem’s strong technology platform to manufacture high-profile proprietary compounds as well as develop innovative processes to add significant value within their supply chains.

  • 6 industrial sites

– All pharma sites are USFDA / LVWA / ANSM approved

  • 5 R&D sites
  • Core businesses

– API : generics/innovators, high potent

– Custom Development Manufacturing

– Niche chemistry

  • General information

– 155 M€ (2016)

– 750 employees (2016)

Today, the largest pharmaceutical and biopharmaceutical relies on Minakem’s strong technology platform to manufacture high-profile proprietary compounds as well as develop innovative processes to add significant value within their supply chains.

Visit Minafin Group’s website

MINAFIN core business activities:

Minafin Group

  • API manufacture at small and large scale
  • Custom Manufacturing of Key Intermediates
  • Synthesis of Starting Materials and Building Blocks
  • Dedicated, FDA inspected facilities capable of running both cGMP and non-GMP processes
  • Research and Development Center
  • Strong R&D team focusing Process Development, Optimization and Solid Form studies
  • Project Management & Regulatory Stewardship